Iterum Therapeutics Plc (ITRM) Tops Q2 EPS by 15c
Tweet
Share
E-mailGet Alerts ITRM Hot Sheet
Join SI Premium – FREE
Iterum Therapeutics Plc (NASDAQ: ITRM) reported Q2 EPS of ($0.30), $0.15 better than the analyst estimate of ($0.45).
For earnings history and earnings-related data on Iterum Therapeutics Plc (ITRM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AeroVironment (AVAV) Tops Q4 EPS by 36c
- Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
- Texas Capital Securities Starts IperionX (IPX) at Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
